Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
NCT01343355
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
HTLV-I-Associated Myelopathy
Interventions
DRUG:
Tamibarotene
Sponsor
St. Marianna University School of Medicine